Our prior research demonstrated that ASX ameliorated the OS in HGCs (Eslami et al., 2021) and PCOS patients (Gharaei et al., 2022) by increasing the expression of HO‐1 and NQ‐1 through NRF2 activation. This evidence concerns the gene HMOX1 and polycystic ovary syndrome.